Spain Anti-infective Agents Market Size & Outlook
Spain anti-infective agents market, 2018-2030 (US$M)
Related Markets
Spain anti-infective agents market highlights
- The Spain anti-infective agents market generated a revenue of USD 2,976.7 million in 2024 and is expected to reach USD 3,061.9 million by 2030.
- The Spain market is expected to grow at a CAGR of 0.9% from 2025 to 2030.
- In terms of segment, antivirals was the largest revenue generating type in 2024.
- Antibacterials is the most lucrative type segment registering the fastest growth during the forecast period.
Anti-infective agents market data book summary
| Market revenue in 2024 | USD 2,976.7 million |
| Market revenue in 2030 | USD 3,061.9 million |
| Growth rate | 0.9% (CAGR from 2025 to 2030) |
| Largest segment | Antivirals |
| Fastest growing segment | Antibacterials |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibacterials, Antivirals, Antifungals |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, Spain accounted for 2.2% of the global anti-infective agents market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany anti-infective agents market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 5,159.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-infective Agents Market Scope
Anti-infective Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain anti-infective agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 46.3% in 2024. Horizon Databook has segmented the Spain anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
Spain’s anti-infective agents market is growing steadily, driven by rising infection rates and a strong focus on research within the pharmaceutical sector. According to Eurosurveillance, from 2014 to 2021, Spain reported 6,389 cases of healthcare-associated infections (HAIs) caused by multidrug-resistant bacteria.
The most frequently identified bacteria were Klebsiella spp. (46.3%), Staphylococcus aureus (18.5%), and Escherichia coli (16.8%). These infections were primarily diagnosed in departments of internal medicine and infectious diseases, as well as adult intensive care units.
Reasons to subscribe to Spain anti-infective agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain anti-infective agents market databook
-
Our clientele includes a mix of anti-infective agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into Spain anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain anti infective agents market size, by type, 2018-2030 (US$M)
Spain Anti-infective Agents Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
